SCHEMBL23062796

SCHEMBL23062796

Cc1n[nH]c2ccc(O)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 4/20 0.53
MAPK1 P28482 3/20 0.53
MAPKAPK2 P49137 2/20 0.53
MAPKAPK3 Q16644 2/20 0.53
MAPK6 Q16659 2/20 0.53
MAPKAPK5 Q8IW41 1/20 0.53
ADORA2A P29274 1/20 0.46
ADORA2B P29275 1/20 0.46
PDPK1 O15530 1/20 0.46
HSP90AB1 P08238 1/20 0.46
ESR1 P03372 1/20 0.43
CYP1A2 P05177 2/20 0.43
FGFR3 P22607 2/20 0.41
KIT P10721 1/20 0.41
PDGFRA P16234 1/20 0.41
FGFR1 P11362 1/20 0.41
FGFR2 P21802 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12907439 0.85 MAPK1 (0.59) MAP2K4MAPK1MAPKAPK2MAPKAPK3MAPK6
SCHEMBL176952 0.84 PDPK1 (0.59) MAP2K4MAPK1MAPKAPK2MAPKAPK3MAPK6
SCHEMBL12907433 0.81 MKNK1 (0.51) MAP2K4MAPK1MAPKAPK2MAPKAPK3MAPK6
SCHEMBL29769133 0.79 MAP2K4 (0.57) MAP2K4MAPK1MAPKAPK2MAPKAPK3MAPK6
SCHEMBL12222 0.79 MAP2K4 (0.57) MAP2K4MAPK1MAPKAPK2MAPKAPK3MAPK6
SCHEMBL10130802 0.78 JAK2 (0.60) MAP2K4MAPK1MAPKAPK2MAPKAPK3MAPK6
SCHEMBL6618549 0.77 ADORA2A (0.43) MAP2K4MAPK1MAPKAPK2MAPKAPK3MAPK6
SCHEMBL18535138 0.76 PDPK1 (0.46) MAP2K4MAPK1MAPKAPK2MAPKAPK3MAPK6
Hydrochloric Acid SCHEMBL10369298 0.76 JAK2 (0.58) MAP2K4MAPK1MAPKAPK2MAPKAPK3MAPK6
SCHEMBL24149246 0.76 ADORA2A (0.46) MAP2K4MAPK1MAPKAPK2MAPKAPK3MAPK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025129167-A1 INHIBITORS OF THE SURFACE EXPRESSION OF THE VOLTAGE-GATED SODIUM ION CHANNEL 1.7 (NAV1.7) AND THEIR THERAPEUTIC USES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2025-06-19 WO disclosed
WO-2021041237-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. (US) 2021-03-04 WO disclosed